Stock Events

Pfizer 

$28.88
17196
+$0.19+0.66% Friday 20:00

Statistics

Day High
28.99
Day Low
28.55
52W High
38.23
52W Low
24.83
Volume
22,309,182
Avg. Volume
45,102,727
Mkt Cap
163.65B
P/E Ratio
-530.88
Dividend Yield
5.82%
Dividend
1.68

Upcoming

Dividends

5.82%Dividend Yield
10Y Growth
4.91%
5Y Growth
3.13%
3Y Growth
2.5%
1Y Growth
2.44%

Earnings

1MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.18
0.47
1.13
1.78
Expected EPS
0.53
Actual EPS
0.82

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PFE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Analyst Ratings

33.63$Average Price Target
The highest estimate is $45.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
44%
Hold
56%
Sell
0%

About

Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Show more...
CEO
Employees
88000
Country
US
ISIN
US7170811035
WKN
000852009

Listings